Dr. Mark N. Halikis, MD

Dr. Halikis practices at Hoag Orthopedic Institute Surgery Center Orange in Orange, California.

Dr. Halikis' NPI, 1114914397, was assigned on October 3, 2005. Dr. Halikis graduated from Keck School of Medicine of USC in 1988. Dr. Halikis holds California license G68749.

Dr. Halikis' primary practice is Hoag Orthopedic Institute Surgery Center Orange, at 280 S Main St Ste 100, Orange, CA 92868. The practice phone is (714) 704-1900.

Dr. Halikis' primary practice is Hoag Orthopedic Institute Surgery Center Orange in Orange, California. Dr. Halikis is also affiliated with Providence St. Joseph Hospital Orange. The medical group on file is Orthopaedic Specialty Institute. Dmand AI also links Dr. Halikis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Halikis practices, 3 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Halikis' primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Halikis is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dr. Halikis is licensed in California.

Dmand AI lists arm, wrist, hand fracture and dislocation, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation and joint cyst among the conditions Dr. Halikis treats.

CMS data shows 2,594 Medicare services from Dr. Halikis across 22 procedure codes in 2024, for 403 Medicare patients. Medicare paid $131,124 for them.

CMS counts 403 Medicare patients who saw Dr. Halikis in 2024. The largest group is 65 to 74, with 182 patients. 75% of them have high cholesterol, and 71% have arthritis. 12% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Halikis' median patient age at 62, with 50% women.

In 2024, Dr. Halikis wrote 175 Medicare Part D claims for 107 patients. 100% of them were for generic drugs. CMS names the drug for 131 of them, across 5 drugs with 11 or more claims each, at $1,235 in total drug cost. In 2023, CMS named 176 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Halikis for performance year 2024, reported as part of a group. Dr. Halikis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Halikis in 2024. The most frequent topics are Carpal Bones, Joint Instability and Range of Motion, Articular. Dr. Halikis has published most often in J Hand Surg Am. Dr. Halikis' most frequent co-authors are Julio Taleisnik, MD, Juston Fan, DO and Amirhossein Misaghi, MD.

CMS Open Payments shows 22 general payments to Dr. Halikis from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Endo Pharmaceuticals Inc. paid the most, $444.

Dmand AI lists 1 award for Dr. Halikis, most recently CMS Stage 1 EHR in 2013.

Dr. Halikis graduated from Keck School of Medicine of USC in 1988.

Dr. Halikis is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.